Genuit Group/£GEN
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Genuit Group
Polypipe Group, trading under the ticker GEN, is a manufacturer specializing in water management and plastic piping systems. Established in 1980, the company operates primarily within the construction and infrastructure sectors. Polypipe offers a wide range of products aimed at addressing critical challenges in water, climate, and ventilation management, contributing to the development of green building solutions.
- Ticker
- £GEN
- Sector
- Industrials
- Primary listing
- LSE
- Employees
- 3,274
- Headquarters
- Leeds, United Kingdom
- Website
- www.genuitgroup.com
Genuit Group Metrics
BasicAdvanced
£721M
21.46
£0.13
1.44
£0.13
4.48%
Price and volume
Market cap
£721M
Beta
1.44
52-week high
£3.92
52-week low
£2.41
Average daily volume
1.3M
Dividend rate
£0.13
Financial strength
Current ratio
1.464
Quick ratio
0.998
Long term debt to equity
0.353
Total debt to equity
0.366
Dividend payout ratio (TTM)
94.46%
Interest coverage (TTM)
6.49%
Profitability
EBITDA (TTM)
112.3
Gross margin (TTM)
43.90%
Net profit margin (TTM)
5.60%
Operating margin (TTM)
12.51%
Effective tax rate (TTM)
24.78%
Revenue per employee (TTM)
£190,000
Management effectiveness
Return on assets (TTM)
4.58%
Return on equity (TTM)
5.25%
Valuation
Price to earnings (TTM)
21.457
Price to revenue (TTM)
1.178
Price to book
1.09
Price to tangible book (TTM)
-288.01
Price to free cash flow (TTM)
8.883
Free cash flow yield (TTM)
11.26%
Free cash flow per share (TTM)
0.324
Dividend yield (TTM)
4.48%
Growth
Revenue change (TTM)
4.33%
Earnings per share change (TTM)
-30.71%
3-year revenue growth (CAGR)
0.17%
10-year revenue growth (CAGR)
4.20%
3-year earnings per share growth (CAGR)
-1.15%
10-year earnings per share growth (CAGR)
-3.90%
3-year dividend per share growth (CAGR)
1.60%
10-year dividend per share growth (CAGR)
4.14%
What the Analysts think about Genuit Group
Analyst ratings (Buy, Hold, Sell) for Genuit Group stock.
Analyst projections of the future price of Genuit Group stock.
Bulls say / Bears say
Genuit is exposed to multi-year demand drivers rather than only new housebuilding. The Future Homes Standard, Warm Homes Plan, social housing policy and AMP8 water investment are building a larger pipeline, with AMP8 orders above £2m and quoted work up to £9m. (Genuit Group, Investegate)
The 2025 acquisitions are adding higher-quality earnings. The Davidson businesses generated an operating margin above 20% in the first half, while Genuit says both acquisitions are integrated and delivering commercial synergies. (Investegate, Investegate)
Management has shown it can protect cash and margins through a weak cycle. Price increases, cost control and the Genuit Business System helped maintain full-year expectations, lifted first-half cash conversion to 71.3%, and should be followed by more than £4m of annualised savings from 2027. (Genuit Group, Investegate)
Underlying demand remains weak across important end markets. First-half like-for-like revenue fell 4.8%, with housing, residential repair and maintenance, and parts of civils and commercial construction all subdued. (Investegate, Investegate)
Input-cost inflation is still a direct threat to profit. Polymer and freight costs rose sharply after the Middle East conflict, while the lag before price rises took effect already reduced margins and management expects difficult conditions to persist through the rest of 2026. (Investegate, Investegate)
The recovery case depends heavily on benefits that may arrive later than hoped. Civils projects have been delayed, the main structural opportunities are expected to build from 2027, and first-half statutory operating profit fell 30.1% while leverage stood at 1.6 times pro-forma EBITDA after acquisitions. (Investegate, Investegate)
Data summarised monthly by Lightyear AI. Last updated on 28 Sept 2026.
Genuit Group Financial Performance
Revenues and expenses
Genuit Group Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing Genuit Group
AllGBPEURUSD
Fund name | Fund size | £GEN weighting |
|---|---|---|
iShares FTSE 250£MIDD | £661M | 0.23% |
Vanguard FTSE 250£VMID | £1.6B | 0.21% |
Xtrackers MSCI Europe Small Cap€DX2J | €3.2B | 0.06% |
Xtrackers MSCI Europe Small Cap£XXSC | £2.8B | 0.06% |
L&G Global Quality Dividends£LDGG | £279M | 0.02% |
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by London Stock Exchange, through Infront.